Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes. Diabetic macroangiopathies, particularly cardiovascular (CV) diseases, seems closely related to diabetes microvascular complications. Aspirin represents the most prescribed compound in CV prevention. Aspirin impact on DR is still object of debate. As aspirin is already recommended among diabetics at high CV risk, aim of this study was to assess a potential relationship between DR and aspirin therapy, in a type 2 diabetes cohort of patients screened through telemedicine.

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - June 28, 2020 Category: Nutrition Authors: Pia Clara Pafundi, Raffaele Galiero, Alfredo Caturano, Carlo Acierno, Chiara de Sio, Erica Vetrano, Riccardo Nevola, Aldo Gelso, Valeria Bono, Ciro Costagliola, Raffaele Marfella, Celestino Sardu, Luca Rinaldi, Teresa Salvatore, Luigi Elio Adinolfi, Ferdi Source Type: research